Resultado da Busca
Launched in April 2020, the REACT programme began as one of the world’s largest and most comprehensive coronavirus monitoring studies. The programme is led by a world-class team of researchers at Imperial College London in partnership with Ipsos MORI and commissioned by the Department of Health and Social Care.
3 de dez. de 2021 · Dr Joseph Gibbons Study author from Queen Mary University of London. Dr Catherine Reynolds, from Imperial College London, said: "Our study highlights the importance of understanding the immune responses to the different SARS-CoV-2 variants in the context of existing vaccines, in order to make informed decisions about future vaccine design ...
28 de out. de 2021 · Fully vaccinated people can contract and pass on COVID-19 in the home, but at lower rates than unvaccinated people. These are the findings of a study of COVID-19 transmission between household contacts, led by Imperial College London and the UK Health Security Agency (HSA) and published today in The Lancet Infectious Diseases.
These donations come as part of a groundswell of support from the College’s alumni and donor community, which has seen hundreds pledge a gift to support Imperial’s COVID-19 response. To discuss a gift to support COVID-19 vaccine research at Imperial College London, please contact Angela Bowen (Director of Development, Faculty of Medicine) on +44 (0)20 7594 1277 or email angela.bowen ...
14 de mai. de 2021 · Led by Imperial College London’s Institute of Global Health Innovation, the report shares insights from an ongoing international survey established in partnership with YouGov, which is tracking COVID-19 related behaviours and attitudes. "This programme helps ensure that responses to COVID-19 are successful."
10 de jan. de 2022 · People with higher levels of T cells from common cold coronaviruses are less likely to become infected with SARS-CoV-2. A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T cells.
20 de jul. de 2023 · Patient-led start-up Visible has launched two app-based health studies in collaboration with researchers at Imperial College London. Since it launched in November 2022, over 30,000 people with Long COVID or myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) have been using the Visible app to find patterns in their illness, and adjust their lifestyles to avoid symptom flare-ups.
